Inter-Excellence granty

INTER-COST

Phosphazene Immobilized Photoswitches; Quest for Universal Sensors/Fotopřepínače imobilizované na fosfazenech – hledání univerzálních senzorů. No: LUC24043 (MŠMT), 2024–2027 (Eliška Procházková)
NMR Crystallography of Molecular solids/NMR krystalografie molekulárních pevných látek. No: LUC24101 (MŠMT), 2024–2027 (Martin Dračínský)
Evolution of terpenoid biosynthesis in insects/Evoluce biosyntézy terpenoidů u hmyzu. No: LUC24118 (MŠMT), 2024–2027 (Robert Hanus)
Targeting cathepsin-mediated proteolysis for proteostasis control. No: LUC23037 (MŠMT), 2023–2025 (Martin Horn)
The role of proteases and pseudoproteases in membrane protein biogenesis and quality control. No: LUC23180 (MŠMT), 2023–2025 (Kvido Stříšovský)
Impact of Photoinduced Charge Migration on Photochemistry of Radicals and Switches. No: LTC20076 (MŠMT), 2020–2023 (Tomáš Slanina)
Role of adhesion-GPCRs during viral infection of mammalian cells. No: LTC20065 (MŠMT), 2020–2023 (Jan Weber)
Development of chiral microscopy and chemical imaging for biomolecular studies. No: LTC17012 (MŠMT), 2017–2020 (Petr Bouř)

Utilizing CD64-specific synthetic antibody mimetics for cancer immunotherapy and immunomodulation/Využití syntetických mimetik protilátek specifických pro CD64 pro imunoterapii a imunomodulaci nádorových onemocnění. No: LUAIZ24161 (MŠMT), 2024–2027 (Jan Konvalinka spolu s Jakubem Abramsonem, Weizmann Institute of Science)

Activation of bio-abundant organic feedstocks: acridinia as electrorecyclable, multifunctional catalysts with unique organocatalytic umpolung reactivity. No: LUABA24172 (MŠMT), 2024–2026 (Tomáš Slanina spolu s Joshuou Barhamem, Universitaet Regensburg)

Biocatalysis inspired by reactive intermediates in copper oxidases and oxygenases: an interplay between theory and experiment. No: LUAUS24230 (MŠMT), 2024–2027 (Lubomír Rulíšek spolu s Edwardem I. Solomonem, Stanford University)
Nonplanar and chiral nanocarbons: their synthesis, properties and applications. No: 24212 (MŠMT), 2024–2027 (Ivo Starý spolu se Semin Lee, Louisiana State University)

Development of Non-Opioid Calcium Antagonists for Pain Treatment/Vývoj nových neopioidních antagonistů vápníkových kanálů pro léčbu bolesti. No: LUAUS23322 (MŠMT), 2023–2026 (Emanuela Jahn spolu s New York University)
Multifunctional Molecular Machines/Multikomponentní molekulární stroje. No: LUAUS23144 (MŠMT), 2023–2027 (Jiří Kaleta spolu s Ohio University)
Development of new chemotherapeutics against human and veterinary parasitic infections/Vývoj nových chemoterapeutik proti humánním a veterinárním parazitárním infekcím. No: LUAUS23050 (MŠMT), 2023–2027 (Michael Mareš spolu s University of California)

Electron and proton transfer in ionized DNA fragments. No: LTAUSA19094 (MŠMT), 2020–2022 (Aleš Marek)
When Cucurbit[n]urils Met Molecular Rods: Design, Synthesis and Characterization of Supramolecular Machines in the Solid State. No: LTAUSA19120 (MŠMT), 2020–2022 (Jiří Kaleta)
Mono- and binuclear Fe, Cu active sites in biological systems: interplay between theory and experiment. No: LTAUSA19148 (MŠMT), 2020–2022 (Lubomír Rulíšek)
Novel strategies for designing antiparasitic molecules as human and veterinary drugs. No: LTAUSA19109 (MŠMT), 2020–2022 (Michael Mareš)

Photoswitchable and Magnetic Photoswitchable Ionic Liquids: Theory and Experiments. No: LTAIN19166 (MŠMT), 2020–2022 (Tomáš Slanina)
Visualizing GPCR-G-protein-β-arrestin supercomplexes in living cells using two-photon polarization microscopy. No: LTAIN19167 (MŠMT), 2020–2022 (Josef Lazar)

Embedding Antiviral Nanoparticles in Water and/or Air for Cleaning the Environment. No: LTAIZ19017 (MŠMT), 2019–2022 (Jan Weber)

Synthesis and reactivity of N-fluoroalkylated compounds. No: LTAUSA18037 (MŠMT), 2019–2022 (Petr Beier)
Design, synthesis and biological evaluation of potential modulators of human adenylate cyclases. No: 18086 (MŠMT), 2019–2022 (Zlatko Janeba)
Poly-β-malic acid and its role as a possible primitive predecessor of nucleic acids. No: LTAUSA18085 (MŠMT), 2019–2022 (Jakub Kaminský)
Tumor targeted prodrugs of glutamine anatagonists. No: LTAUSA18166 (MŠMT), 2019–2022 (Pavel Majer)
Search for novel nucleoside analogs as antivirals against medically important flaviviruses. No: LTAUSA18018 (MŠMT), 2019–2022 (Radim Nencka)